References
- Worek F, Wille T, Koller M, Thiermann H. Toxicology of organophosphorus compounds in view of an increasing terrorist threat. Arch Toxicol 2016;90:2131–45. doi: 10.1007/s00204-016-1772-1
- Worek F, Thiermann H, Wille T. Oximes in organophosphate poisoning: 60 years of hope and despair. Chem Biol Interact 2016;259:93–8. doi: 10.1016/j.cbi.2016.04.032
- Katalinić M, Šinko G, Maček Hrvat N, Zorbaz T, Bosak A, Kovarik Z. Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations. Toxicology 2018;406–407:104–13. doi: 10.1016/j.tox.2018.05.008
- Gašo-Sokač D, Katalinić M, Kovarik Z, Bušić V, Kovač S. Synthesis and evaluation of novel analogues of vitamin B6 as reactivators of tabun and paraoxon inhibited acetylcholinesterase. Chem Biol Interact 2010;187:234–7. doi: 10.1016/j.cbi.2010.02.004
- Zorbaz T, Braïki A, Maraković N, Renou J, de la Mora E, Maček Hrvat N, Katalinić M, Silman I, Sussman JL, Mercey G, Gomez C, Mougeot R, Pérez B, Baati R, Nachon F, Weik M, Jean L, Kovarik Z, Renard PY. Potent 3-hydroxy-2-pyridine aldoxime reactivators of organophosphate-inhibited cholinesterases with predicted blood-brain barrier penetration. Chemistry 2018;24:9675–91. doi: 10.1002/chem.201801394
- Zorbaz T, Malinak D, Maraković N, Maček Hrvat N, Zandona A, Novotny M, Skarka A, Andrys R, Benkova M, Soukup O, Katalinić M, Kuca K, Kovarik Z, Musilek K. Pyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents. J Med Chem 2018;61:10753–66. doi: 10.1021/acs.jmedchem.8b01398
- Zandona A, Katalinić M, Šinko G, Radman Kastelic A, Primožič I, Kovarik Z. Targeting organophosphorus compounds poisoning by novel quinuclidine-3 oximes: development of butyrylcholinesterase-based bioscavengers. Arch Toxicol 2020;94:3157–71. doi: 10.1007/s00204-020-02811-5
- Horn G, Wille T, Musilek K, Kuca K, Thiermann H, Worek F. Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase. Arch Toxicol 2015;89:405–14. doi: 10.1007/s00204-014-1288-5
- Gorecki L, Junova L, Kucera T, Hepnarova V, Prchal L, Kobrlova T, Muckova L, Soukup O, Korabecny J. Tacroximes: novel unique compounds for the recovery of organophosphorus-inhibited acetylcholinesterase. Future Med Chem 2019;11:2625–34. doi: 10.4155/fmc-2019-0027
- Taylor P, Yan-Jye S, Momper J, Hou W, Camacho-Hernandez GA, Radić Z, Rosenberg Y, Kovarik Z, Sit R, Sharpless KB. Assessment of ionizable, zwitterionic oximes as reactivating antidotal agents for organophosphate exposure. Chem Biol Interact 2019;308:194–7. doi: 10.1016/j.cbi.2019.05.015
- Radman Kastelic A, Odžak R, Pezdirc I, Sović K, Hrenar T, Čipak Gašparović A, Skočibušić M, Primožič I. New and potent quinuclidine-based antimicrobial agents. Molecules 2019;24(14):2675. doi: 10.3390/molecules24142675
- Skočibušić M, Odžak R, Štefanić Z, Križić I, Krišto L, Jović O, Hrenar T, Primožič I, Jurašin D. Structure-property relationship of quinuclidinium surfactants - Towards multifunctional biologically active molecules. Colloids Surfaces B Biointerfaces 2016;140:548–59. 10.1016/j.colsurfb.2015.11.023
- Topcu S, Ozen T, Bal A, Tas M. Synthesis, characterization and antioxidant activities of some novel oxime derivatives. Pharm Pharmacol Int J 2021;9:176–92. doi: 10.15406/ppij.2021.09.00343
- Schepetkin IA, Plotnikov MB, Khlebnikov AI, Plotnikova TM, Quinn MT. Oximes: novel therapeutics with anticancer and anti-inflammatory potential. Biomolecules 2021;11(6):777. doi: 10.3390/biom11060777
- Zandona A, Maraković N, Mišetić P, Madunić J, Miš K, Padovan J, Pirkmajer S, Katalinić M. Activation of (un)regulated cell death as a new perspective for bispyridinium and imidazolium oximes. Arch Toxicol 2021;95:2737–54. doi: 10.1007/s00204-021-03098-w
- Zorbaz T, Malinak D, Maraković N, Maček Hrvat N, Zandona A, Novotny M, Skarka A, Andrys R, Benkova M, Soukup O, Katalinić M, Kuca K, Kovarik Z, Musilek K. Pyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents. J Med Chem 2018;61:10753–66. doi: 10.1021/acs.jmedchem.8b01398
- Katalinić M, Maček Hrvat N, Baumann K, Morasi Piperčić S, Makarić S, Tomić S, Jović O, Hrenar T, Miličević A, Jelić D, Žunec S, Primožič I, Kovarik Z. A comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers. Toxicol Appl Pharmacol 2016;310:195–204. doi: 10.1016/j.taap.2016.09.015
- Pirkmajer S, Bezjak K, Matkovič U, Dolinar K, Jiang LQ, Miš K, Gros K, Milovanova K, Pirkmajer KP, Marš T, Kapilevich L, Chibalin AV. Ouabain suppresses IL-6/STAT3 signaling and promotes cytokine secretion in cultured skeletal muscle cells. Front Physiol 2020;11:566584. doi: 10.3389/fphys.2020.566584
- Zandona A, Lihtar G, Maraković N, Miš K, Bušić V, Gašo-Sokač D, Pirkmajer S, Katalinić M. Vitamin B3-based biologically active compounds as inhibitors of human cholinesterases. Int J Mol Sci 2020;21(21):8088. doi: 10.3390/ijms21218088
- Gros K, Matkovič U, Parato G, Miš K, Luin E, Bernareggi A, Sciancalepore M, Marš T, Lorenzon P, Pirkmajer S. Neuronal agrin promotes proliferation of primary human myoblasts in an age-dependent manner. Int J Mol Sci 2022;23:11784. doi: 10.3390/ijms231911784
- Martínez M, Martínez N, Silva W. Measurement of the intracellular calcium concentration with Fura-2 AM using a fluorescence plate reader. Bio Protoc 2017;7(14):e2411. doi: 10.21769/BioProtoc.2411
- Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 2019;47:W357–64. doi: 10.1093/nar/gkz382
- Gfeller D, Michielin O, Zoete V. Shaping the interaction landscape of bioactive molecules. Bioinformatics 2013;29:3073–9. doi: 10.1093/bioinformatics/btt540
- Chaban Y, Boekema EJ, Dudkina NV. Structures of mitochondrial oxidative phosphorylation supercomplexes and mechanisms for their stabilisation. Biochim Biophys Acta 2014;1837:418–26. doi: 10.1016/j.bbabio.2013.10.004
- Leist M, Single B, Castoldi AF, Kühnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997;185:1481–6. doi: 10.1084/jem.185.8.1481
- Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, Haque SJ. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 2002;21:8404–13. doi: 10.1038/sj.onc.1206047
- Theivendren P, Kunjiappan S, Mariappa Hegde Y, Vellaichamy S, Gopal M, Rajan Dhramalingam S, Kumar S. Importance of protein kinase and its inhibitor: a review. In: Singh RK, editor. Protein kinases - promis. Targets anticancer drug research. IntechOpen Series Biochemistry. Vol 24, 2021. p. 75–100. doi: 10.5772/intechopen.98552
- Roskoski R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 2012;66:105–43. doi: 10.1016/j.phrs.2012.04.005
- John P Konhilas YL. AMP-activated protein kinase signalling in cancer and cardiac hypertrophy. Cardiovasc Pharm Open Access 2015;4(3):154. doi: 10.4172/2329-6607.1000154
- Soukup O, Korabecny J, Malinak D, Nepovimova E, Pham NL, Musílek K, Hrabinova M, Hepnarova V, Dolezal R, Pavek P, Kobrlova T, Jankockova J, Gorecki L, Psotka M, Thuy D, Box K, Outhwaite B, Ceckova M, Sorf A, Jun D, Kuca K. In vitro and in silico evaluation of non-quaternary reactivators of AChE as antidotes of organophosphorus poisoning - a new hope or a blind alley? Med Chem (Los Angeles) 2018;14:281–92. doi: 10.2174/1573406414666180112105657
- Bong AHL, Monteith GR. Calcium signaling and the therapeutic targeting of cancer cells. Biochim Biophys Acta Mol Cell Res 2018;1865:1786–94. doi: 10.1016/j.bbamcr.2018.05.015